Innovation Blogs

06|13|25

AI in Oncology: Solving the Sequencing Puzzle in a Biomarker-Driven Era

At ASCO 2025, artificial intelligence took center stage as a real-world solution to one of oncology’s most complex challenges: sequencing treatments in a rapidly expanding biomarker landscape. In a recent PharmaLive article, Tim Lewis, EVP of Strategic Development, Oncology and Precision Medicine at EVERSANA INTOUCH, shared how AI is helping oncologists make faster, smarter decisions when evidence is […]

06|10|25

AI, Biomarkers & The Future of Oncology: Expert Insights From ASCO 2025 

At this year’s ASCO Annual Meeting, the future of oncology came into sharper focus — and EVERSANA INTOUCH was at the center of the conversation. From the expanding role of AI to the evolving biomarker landscape, our experts shared insights that are shaping the future of cancer care. 

05|21|25

Big Moves for Bigger Impact: Elevating Agency Leadership to Enhance Client Success

EVERSANA INTOUCH announced new leadership appointments in a recent press release. Read the blog for details about the leadership changes and how they will enhance client success.

05|21|25

EVERSANA Elevates Agency Leadership Team with Key Talent to Drive Innovation and Maximize Impact for Pharma Brands

CHICAGO– May 21, 2025 – EVERSANA, a leading provider of commercial services to the life sciences industry, today announced new appointments to the company’s global agency network, EVERSANA INTOUCH, to meet growing client needs.

04|11|25

EVERSANA Unveils EVERSANA ORCHESTRATE™ MLR to Transform the Medical, Legal & Regulatory Process

CHICAGO – 10 April, 2025 – EVERSANA, a leading provider of commercial services to the life sciences industry, today announced the next milestone in its journey to transform and innovate commercialization with the launch of ​​EVERSANA ORCHESTRATE MLR, an AI-powered, industry-integrated platform that revolutionizes the Medical, Legal, and Regulatory (MLR) process. 

02|28|25

Make a Difference in Rare Disease With Creativity, Data, and Innovation: Insights from Ann Cave

Learn the key takeaways and insights from a recent Med Ad News article about how to make a difference in rare disease marketing with creativity, data and innovation.

12|03|24

The Balancing Act: Sourcing & Pricing Meet Innovation in Life Sciences

EVERSANA INTOUCH recently hosted an insightful panel at the 2024 ProcureCon Marketing conference in Los Angeles. The panel, titled "The Balancing Act: Sourcing & Pricing Meet Innovation in Life Sciences," brought together industry leaders to discuss the intersection of cost efficiency and innovation in the dynamic field of life sciences. Read the blog to learn more.

12|02|24

What AI Means for DTC Marketing

In the rapidly evolving landscape of direct-to-consumer (DTC) marketing, artificial intelligence (AI) is emerging as a transformative force. For large pharmaceutical companies and their senior brand marketers, understanding and leveraging AI can significantly enhance the effectiveness and efficiency of their marketing strategies. Here’s how AI is reshaping DTC marketing and what it means for the industry.

11|18|24

What Matters Most: The Three Trends That Will Change Pharma Marketing in 2025

This year’s EVERSANA INTOUCH trends forecast spotlights three powerful, digitally driven forces—applied AI, direct-to-patient models, and globalization—reshaping pharma marketing, with expert insights and recommendations to help you succeed in 2025 and beyond.

10|07|24

How AI Makes the Voice of the Consumer Louder

Artificial intelligence is revolutionizing the way companies make marketing decisions. John Kenny, EVP and Head of Strategic Planning, delves into the innovative use of AI-powered personas to keep the customer’s perspective central in marketing strategies.